Business & Scientific Resources

Wellcome and the UK Department for International Development (DFID) through the Joint Initiative on Research in Epidemic Preparedness and Response are providing funding to prevent and control COVID-19. 

The EMA will fully waive fees for scientific advice to drugmakers developing potential treatments or vaccines for the novel coronavirus disease (COVID-19).

President Trump released an Executive Order preventing hoarding or price gauging health and medical resources to prevent the spread of coronavirus.

Fast Grants are available for scientists at an academic institution currently working on a COVID-19.

FDA issued guidance for Industry, Investigators, and Institutional Review Boards.

At Arnold & Porter, we are client-driven and industry-focused. Our lawyers practice in more than 40 practice areas across the litigation, regulatory and transactional spectrum to help clients with complex needs stay ahead of the global market, anticipate opportunities and address issues that…

FDA has been monitoring the drug supply chain and communicating with manufacturers related to the possibility of shortages of drugs, API, and related supplies.

FEMA has issued an advisory regarding coronavirus and actions companies can take to help fight the COVID-19 pandemic.

The Antitrust Division of the Department of Justice and the Bureau of Competition of the Federal Trade Commission issued joint guidance on how companies can ensure compliance with the federal antitrust laws.

The U.S. Centers for Disease Control and Prevention (CDC) is working to help Ministries of Health meet key International Health Regulations (IHR) (2005) requirements through implementation of the GHSA.

MIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak

This checklist is designed as a quick reference for healthcare enterprise management to consider important factors in a teleworking strategy.